Clarius Group, LLC Vir Biotechnology, Inc. Transaction History
Clarius Group, LLC
- $1.44 Billion
- Q4 2024
A detailed history of Clarius Group, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 57,193 shares of VIR stock, worth $594,807. This represents 0.03% of its overall portfolio holdings.
Number of Shares
57,193
Previous 57,193
-0.0%
Holding current value
$594,807
Previous $428,000
2.1%
% of portfolio
0.03%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding VIR
# of Institutions
216Shares Held
85.1MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$174 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$171 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$137 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$58.5 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$37.2 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.38B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...